临床药物治疗杂志
臨床藥物治療雜誌
림상약물치료잡지
CLINICAL MEDICATION JOURNAL
2013年
5期
41-45
,共5页
刘洋%郭桂明%范峥%王宏蕾
劉洋%郭桂明%範崢%王宏蕾
류양%곽계명%범쟁%왕굉뢰
药物不良反应%监测%分析%合理用药
藥物不良反應%鑑測%分析%閤理用藥
약물불량반응%감측%분석%합리용약
Adverse drug reactions%Rational use of drugs%Traditional Chinese medicines
目的:探讨我院药物不良反应(ADR)发生的特点,为临床合理用药及药品安全性评价提供参考。方法:对我院2012年收集到的90例有效ADR报告进行统计分析。结果:90例ADR报告中,66例19~65岁患者发生ADR,占73.33%;静脉注射给药引发的ADR 43例,占47.78%;最易引起ADR的药物为中药制剂41例,占49.38%,其次为抗感染药物19例,占21.11%;ADR损害类型主要以皮肤及其附件损害为主(32例,占36%);新的ADR 32例,主要为中药制剂引发;严重ADR9例,其中皮肤及其附件损害为6例。结论:临床应重视和加强ADR监测,合理用药,减少ADR的发生。
目的:探討我院藥物不良反應(ADR)髮生的特點,為臨床閤理用藥及藥品安全性評價提供參攷。方法:對我院2012年收集到的90例有效ADR報告進行統計分析。結果:90例ADR報告中,66例19~65歲患者髮生ADR,佔73.33%;靜脈註射給藥引髮的ADR 43例,佔47.78%;最易引起ADR的藥物為中藥製劑41例,佔49.38%,其次為抗感染藥物19例,佔21.11%;ADR損害類型主要以皮膚及其附件損害為主(32例,佔36%);新的ADR 32例,主要為中藥製劑引髮;嚴重ADR9例,其中皮膚及其附件損害為6例。結論:臨床應重視和加彊ADR鑑測,閤理用藥,減少ADR的髮生。
목적:탐토아원약물불량반응(ADR)발생적특점,위림상합리용약급약품안전성평개제공삼고。방법:대아원2012년수집도적90례유효ADR보고진행통계분석。결과:90례ADR보고중,66례19~65세환자발생ADR,점73.33%;정맥주사급약인발적ADR 43례,점47.78%;최역인기ADR적약물위중약제제41례,점49.38%,기차위항감염약물19례,점21.11%;ADR손해류형주요이피부급기부건손해위주(32례,점36%);신적ADR 32례,주요위중약제제인발;엄중ADR9례,기중피부급기부건손해위6례。결론:림상응중시화가강ADR감측,합리용약,감소ADR적발생。
Objective: To explore the characteristics of adverse drug reactions (ADRs) in our hospital in order to provide reference for clinical rational use and safety evaluation of drugs. Methods:We collected 90 cases of ADRs reports in our hospital in 2012 and do statistical analysis. Results:ADRs occurred in 73.33%of patients(66 of 90) aged 19 to 65;ADRs caused by intravenous injection were 47.78% (43 of 90 cases) of patients; the most likely ADRs were caused by traditional Chinese medicines (41 cases, accounting for 49.38%), fol owed by anti nfective drugs (19 cases, 21.11%) ; the main types of ADRs were damage to the skin and its appendents (32 cases, accounting for 36%);There were 32 new ADRs which were mainly related with traditional Chinese medicines;There were 6 cases of damage to the skin and its appendents (66.67%) of 9 cases of serious ADRs . Conclusion: We should pay attention to and strengthen ADR monitoring and rational use of drugs for reducing or avoiding the occurrence of ADRs .